Novavax Inc.

NASDAQ: NVAX · Real-Time Price · USD
9.58
0.15 (1.59%)
At close: Aug 15, 2025, 3:45 PM

Novavax Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
530.23M 568.5M 1.34B 1.52B
Short-Term Investments
392.89M n/a n/a n/a
Long-Term Investments
n/a 4.88M 1.66M 1.65M
Other Long-Term Assets
24M 88.13M 28.47M 56.69M
Receivables
108.28M 297.24M 82.38M 454.99M
Inventory
8.75M 41.7M 36.68M -1.96B
Other Current Assets
32.51M 166.15M 86.68M 56.11M
Total Current Assets
1.13B 1.14B 1.7B 2.16B
Property-Plant & Equipment
300M 490.99M 400.49M 228.7M
Goodwill & Intangibles
107.48M 127.45M 126.33M 136.25M
Total Long-Term Assets
431.48M 711.45M 555.29M 421.63M
Total Assets
1.56B 1.8B 2.26B 2.58B
Account Payables
41.58M 132.61M 216.52M 127.05M
Deferred Revenue
675.07M 241.31M 370.14M 1.42B
Short-Term Debt
7.01M n/a 324.88M n/a
Other Current Liabilities
377.42M 917.36M 982.62M 74.48M
Total Current Liabilities
1.15B 1.64B 2.46B 2.39B
Long-Term Debt
169.68M 168.02M 166.47M 323.46M
Other Long-Term Liabilities
359.61M 90.98M 55.7M 42.12M
Total Long-Term Liabilities
1.03B 937.13M 432.81M 538.11M
Total Liabilities
2.18B 2.51B 2.89B 2.93B
Total Debt
230.42M 229.08M 549.78M 453.99M
Common Stock
1.62M 1.41M 868K 764K
Retained Earnings
-5.01B -4.82B -4.28B -3.62B
Comprehensive Income
-22.56M 2.72M -6.38M -1.35M
Shareholders Equity
-623.84M -716.93M -634.08M -351.67M
Total Investments
392.89M 4.88M 1.66M 1.65M